On Apr. 4, 1977, Donald Kennedy, Ph.D., became Commissioner of the U.S. Food and Drug Administration (FDA). Kennedy, an internationally recognized neurophysiologist headed both the FDA and Stanford University.

Joseph Califano, Secretary of HEW, appointed Kennedy to head FDA in April 1977. During the next 26 months of his tenure as Food and Drug Commissioner the agency dealt with the repercussions of the attempt to ban saccharin, attempted to overhaul the drug provisions of the FD&C Act in the proposed Drug Regulation Reform Act of 1978, and conducted a major revision of many of its good manufacturing practices, among other developments.